We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $911M
1-Year Est. Return 51.11%
This Fund
S&P 500
This Quarter Est. Return
+16.38%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$2.3B
AUM Growth
+$74.7M
Cap. Flow
-$94M
Cap. Flow %
-4.09%
Top 10 Hldgs %
31.66%
Holding
197
New
49
Increased
45
Reduced
38
Closed
57

Sector Composition

Rank Sector Weight
1 Healthcare 19.62%
2 Technology 13.5%
3 Consumer Discretionary 9.32%
4 Industrials 8.53%
5 Consumer Staples 8.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WWAV
101
DELISTED
The WhiteWave Foods Company
WWAV
$4.89M 0.21%
139,905
+23,000
+20% +$816K
CELP
102
DELISTED
Cypress Environmental Partners, L.P.
CELP
$4.86M 0.21%
+340,000
New +$6.47M
DMND
103
DELISTED
DIAMOND FOODS, INC.
DMND
$4.68M 0.2%
165,969
MDVN
104
DELISTED
MEDIVATION, INC.
MDVN
$4.61M 0.2%
92,614
-136,186
-60% -$7.08M
UTHR icon
105
United Therapeutics
UTHR
$22B
$4.61M 0.2%
+35,600
New +$4.59M
RBBN icon
106
Ribbon Communications
RBBN
$388M
$4.36M 0.19%
219,728
-80,000
-27% -$1.42M
SAFM
107
DELISTED
Sanderson Farms Inc
SAFM
$4.12M 0.18%
+49,028
New +$4.22M
SNV
108
DELISTED
Synovus
SNV
$4.06M 0.18%
+150,000
New +$3.79M
EHIC
109
DELISTED
eHi Car Services Limited
EHIC
$3.98M 0.17%
+488,100
New +$5.09M
MNDT
110
PUT
DELISTED
Mandiant, Inc. Common Stock
MNDT
$3.95M 0.17%
125,000
+7,500
+6% +$230K
HZNP
111
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.87M 0.17%
300,000
-900,000
-75% -$11.3M
ICD
112
DELISTED
Independence Contract Drilling, Inc.
ICD
$3.77M 0.16%
36,125
+4,875
+16% +$722K
MTG icon
113
CALL
MGIC Investment
MTG
$6.33B
$3.73M 0.16%
400,000
-300,000
-43% -$2.63M
ACHN
114
CALL
DELISTED
Achillion Pharmaceuticals
ACHN
$3.67M 0.16%
+300,000
New +$3.66M
TNXP icon
115
Tonix Pharmaceuticals
TNXP
$177M
0
XOMA
116
CALL
DELISTED
Xoma
XOMA
$3.27M 0.14%
45,500
OAK
117
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
$3.11M 0.14%
+60,000
New +$2.9M
SGMO
118
CALL
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$3.04M 0.13%
+200,000
New +$2.43M
ATRS
119
DELISTED
Antares Pharma, Inc.
ATRS
$3M 0.13%
1,165,738
KIN
120
DELISTED
Kindred Biosciences, Inc.
KIN
$2.97M 0.13%
398,753
-225,000
-36% -$1.91M
ACHC icon
121
Acadia Healthcare
ACHC
$2.92B
$2.75M 0.12%
45,000
+10,000
+29% +$582K
FCB
122
DELISTED
FCB Financial Holdings, Inc.
FCB
$2.68M 0.12%
+108,900
New +$2.56M
NBIX icon
123
PUT
Neurocrine Biosciences
NBIX
$16.9B
$2.23M 0.1%
+100,000
New +$1.89M
ANF icon
124
Abercrombie & Fitch
ANF
$4.86B
$2.15M 0.09%
+75,000
New +$2.3M
UHS icon
125
Universal Health Services
UHS
$10.1B
$2.15M 0.09%
19,300
-60,000
-76% -$6.3M

Similar funds

Kingdon Capital Management's Q4 2014 Portfolio in Review

As of Q4 2014, Kingdon Capital Management held 197 positions worth $2.3B, up 3.4% from $2.23B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Kingdon Capital Management withdrew a net $94M in Q4 2014, closing 57 positions and reducing 38 holdings. Its most notable exit was Weatherford International plc, an estimated $54.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Kingdon Capital Management opened a new position in Visteon worth $95.5M.

  • Kingdon Capital Management's largest Q4 2014 buy was Visteon: 893,989 shares worth $95.5M.
  • Kingdon Capital Management added most to Tyson Foods in Q4 2014, an estimated $56.2M increase.
  • Kingdon Capital Management's biggest Q4 2014 reduction was HCA Healthcare, cutting an estimated $99.3M.
  • Kingdon Capital Management fully exited Weatherford International plc in Q4 2014, selling an estimated $54.3M.
  • Kingdon Capital Management's ten largest holdings make up 32% of its $2.3B portfolio in Q4 2014.
  • Kingdon Capital Management opened 49 new positions and closed 57 in Q4 2014.
  • Kingdon Capital Management's portfolio value rose 3.4% quarter-over-quarter to $2.3B.

Based on Kingdon Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.